Literature DB >> 28289924

Interleukin-37: A Peacekeeper at the Intestinal Borders.

Luca Pastorelli1,2,3, Theresa T Pizarro4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28289924     DOI： 10.1007/s10620-017-4523-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  15 in total

1.  Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease.

Authors:  Gabriela Fonseca-Camarillo; Janette Furuzawa-Carballeda; Jesús K Yamamoto-Furusho
Journal:  Cytokine       Date:  2015-06-30       Impact factor: 3.861

2.  Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

Authors:  Giovanni Monteleone; Markus F Neurath; Sandro Ardizzone; Antonio Di Sabatino; Massimo C Fantini; Fabiana Castiglione; Maria L Scribano; Alessandro Armuzzi; Flavio Caprioli; Giacomo C Sturniolo; Francesca Rogai; Maurizio Vecchi; Raja Atreya; Fabrizio Bossa; Sara Onali; Maria Fichera; Gino R Corazza; Livia Biancone; Vincenzo Savarino; Roberta Pica; Ambrogio Orlando; Francesco Pallone
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

3.  Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis.

Authors:  Sezin Günaltay; Nils Nyhlin; Ashok Kumar Kumawat; Curt Tysk; Johan Bohr; Olof Hultgren; Elisabeth Hultgren Hörnquist
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Authors:  G Monteleone; A Kumberova; N M Croft; C McKenzie; H W Steer; T T MacDonald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.

Authors:  Simon Weidlich; Ana-Maria Bulau; Tobias Schwerd; Johanna Althans; Roland Kappler; Sibylle Koletzko; Doris Mayr; Philip Bufler
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-08       Impact factor: 2.839

6.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

7.  IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.

Authors:  Claudia A Nold-Petry; Camden Y Lo; Ina Rudloff; Kirstin D Elgass; Suzhao Li; Michael P Gantier; Amelie S Lotz-Havla; Søren W Gersting; Steven X Cho; Jason C Lao; Andrew M Ellisdon; Björn Rotter; Tania Azam; Niamh E Mangan; Fernando J Rossello; James C Whisstock; Philip Bufler; Cecilia Garlanda; Alberto Mantovani; Charles A Dinarello; Marcel F Nold
Journal:  Nat Immunol       Date:  2015-03-02       Impact factor: 31.250

8.  IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice.

Authors:  Wei-qiang Wang; Kui Dong; Lu Zhou; Guo-hui Jiao; Cong-zhong Zhu; Wen-wen Li; Gang Yu; Wan-tong Wu; Song Chen; Zhi-na Sun; Yu-ming Wang; Wen-tian Liu; Jie Zhang; Bang-mao Wang; Xiao-ming Feng
Journal:  Acta Pharmacol Sin       Date:  2015-07-20       Impact factor: 6.150

9.  Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells.

Authors:  Sezin Günaltay; Mohammed Ghiboub; Olof Hultgren; Elisabeth Hultgren Hörnquist
Journal:  Dig Dis Sci       Date:  2017-01-02       Impact factor: 3.199

Review 10.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.